Biopsafe ApS: Financial statements 2017
CVR: 33575505
Source: annual report 2017, Danish Business Authority
01/04/2016 – 31/03/2017
Biopsafe ApS (CVR 33575505) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 557,354 and a net result of DKK -2,230,859 compared with DKK 27,236 the year before. That is a decrease of 70.9% compared with the year before. Equity in the 2017 report amounted to DKK 436,440. The solvency ratio was 2%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 557,354
- Profit/Loss
- DKK -2,230,859
- Equity
- DKK 436,440
- Total Assets
- DKK 22,012,864
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 557 t. | -2.2 mio. | 436 t. | 1 |
| 2016 | - | 1.9 mio. | 27 t. | 167 t. | - |
| 2015 | - | 266 t. | -1 mio. | 140 t. | - |
| 2014 | - | -2 | -222 t. | 111 t. | - |
| 2013 | - | 0 | -43 t. | 83 t. | - |
Keep an eye on Biopsafe ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout Biopsafe ApS
Biopsafe ApS is a Danish company of the type Anpartsselskab based in Vedbæk, founded in 2011. The company is registered under the industry Engroshandel med andre maskiner og andet udstyr. The company was previously named AX-LAB INNOVATION ApS. The management consists of Anne Lykke Gade. The company is owned by MedCap AB (publ). The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 14,274,000 and a net result of DKK 6,231,000 compared with DKK 4,087,000 the year before. Equity in the 2025 report amounted to DKK 11,231,000.